Eli Lilly and Company Profile (NYSE:LLY)

Analyst Ratings

Consensus Ratings for Eli Lilly and (NYSE:LLY) (?)
Ratings Breakdown: 4 Hold Rating(s), 15 Buy Rating(s)
Consensus Rating:Buy (Score: 2.79)
Consensus Price Target: $96.47 (17.52% upside)

Analysts' Ratings History for Eli Lilly and (NYSE:LLY)
Show:
DateFirmActionRatingPrice TargetActions
7/14/2016Jefferies GroupBoost Price TargetBuy$100.00 -> $105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2016Credit Suisse Group AGReiterated RatingBuy$91.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016SunTrust Banks Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2016Morgan StanleyReiterated RatingHold$88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016BMO Capital MarketsLower Price TargetOutperform$95.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2016Societe GeneraleInitiated CoverageHold$78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2016Deutsche Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016Berenberg BankBoost Price TargetBuy$105.00 -> $106.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Goldman Sachs Group Inc.Lower Price TargetNeutral$88.00 -> $86.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Sanford C. BernsteinLower Price TargetOutperform$93.00 -> $92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/15/2016ArgusReiterated RatingBuy$93.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2015Bank of America Corp.Reiterated RatingBuy$104.00 -> $108.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2015Atlantic SecuritiesInitiated CoverageOverweight$100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2015Piper Jaffray Cos.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Citigroup Inc.Lower Price Target$109.00 -> $105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/1/2015Barclays PLCUpgradeEqual Weight -> Overweight$75.00 -> $95.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/21/2015JPMorgan Chase & Co.Boost Price TargetNeutral$83.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2015Cowen and CompanyReiterated RatingOutperform$92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2015Tigress FinancialReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014GuggenheimInitiated CoverageBuy$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2014MKM PartnersBoost Price TargetNeutral$61.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/1/2014S&P Equity ResearchInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Eli Lilly and (NYSE:LLY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/26/2016        
7/26/2016Q216$0.86$0.86$5.14 billion$5.40 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2016Q116$0.85$0.83$4.82 billion$4.87 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2016Q415$0.78$0.78$5.33 billion$5.38 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015Q315$0.76$0.89$4.99 billion$4.96 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2015Q215$0.74$0.90$4.89 billion$4.98 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2015Q115$0.76$0.87$4.62 billion$4.64 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2015Q414$0.74$0.75$5.21 billion$5.12 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014Q314$0.67$0.66$4.83 billion$4.88 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014Q214$0.65$0.68$4.88 billion$4.94 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2014Q114$0.70$0.70$4.78 billion$4.68 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2014Q413$0.72$0.74$5.46 billion$5.81 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2013Q313$1.04$1.11$5.76 billion$5.77 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2013Q2 2013$1.01$1.16$5.82 billion$5.93 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2013Q1 2013$1.05$1.14$5.66 billion$5.60 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2013Q4 2012$0.82$0.85$5.78 billion$5.96 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2012$0.82$0.79ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2012$0.76$0.83ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2012$0.80$0.92ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2012$0.80$0.87ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/20/2011$1.12$1.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/21/2011$1.18$1.18ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/18/2011$1.16$1.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2011$1.10$1.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Eli Lilly and (NYSE:LLY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.80$0.86$0.83
Q2 20163$0.85$0.88$0.86
Q3 20163$0.83$0.90$0.88
Q4 20163$0.94$1.03$0.97
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Eli Lilly and (NYSE:LLY)
Annual Dividend:$2.04
Dividend Yield:2.49%
Payout Ratio:94.01% (Based on Trailing 12 Months of Earnings)
57.30% (Based on Current Year Consensus EPS Estimate)
51.13% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:0.70% (3 Year Average)

Dividend History for Eli Lilly and (NYSE:LLY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
6/20/2016quarterly$0.512.81%8/11/20168/15/20169/9/2016Tweet This Announcement  Share This Announcement on StockTwits
5/2/2016quarterly$0.512.68%5/11/20165/13/20166/10/2016Tweet This Announcement  Share This Announcement on StockTwits
12/8/2015quarterly$0.512.43%2/10/20162/12/20163/10/2016Tweet This Announcement  Share This Announcement on StockTwits
10/19/2015quarterly$0.502.57%11/10/201511/13/201512/10/2015Tweet This Announcement  Share This Announcement on StockTwits
6/15/2015quarterly$0.502.42%8/12/20158/14/20159/10/2015Tweet This Announcement  Share This Announcement on StockTwits
5/4/2015quarterly$0.502.78%5/14/20155/18/20156/10/2015Tweet This Announcement  Share This Announcement on StockTwits
12/15/2014quarterly$0.502.89%2/11/20152/13/20153/10/2015Tweet This Announcement  Share This Announcement on StockTwits
10/20/2014quarterly$0.493.03%11/12/201411/14/201412/10/2014Tweet This Announcement  Share This Announcement on StockTwits
6/16/2014quarterly$0.493.31%8/13/20148/15/20149/10/2014Tweet This Announcement  Share This Announcement on StockTwits
5/5/2014quarterly$0.493.35%5/13/20145/15/20146/10/2014Tweet This Announcement  Share This Announcement on StockTwits
12/16/2013quarterly$0.493.98%2/12/20142/14/20143/10/2014Tweet This Announcement  Share This Announcement on StockTwits
10/21/2013quarterly$0.493.91%11/13/201311/15/201312/10/2013Tweet This Announcement  Share This Announcement on StockTwits
6/18/2013quarterly$0.493.82%8/13/20138/15/20139/10/2013Tweet This Announcement  Share This Announcement on StockTwits
5/6/2013quarterly$0.493.62%5/14/20135/16/20136/10/2013Tweet This Announcement  Share This Announcement on StockTwits
12/17/2012quarterly$0.493.96%2/13/20132/15/20133/8/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Eli Lilly and (NYSE:LLY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/12/2016Lilly Endowment IncMajor ShareholderSell210,000$79.54$16,703,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2016Lilly Endowment IncMajor ShareholderSell225,000$79.14$17,806,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2016Lilly Endowment IncMajor ShareholderSell215,000$78.46$16,868,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/29/2016Lilly Endowment IncMajor ShareholderSell220,000$77.86$17,129,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2016Melissa S BarnesSVPSell992$73.77$73,179.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2016Lilly Endowment IncMajor ShareholderSell200,000$75.12$15,024,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2016Jackson P TaiDirectorBuy1,080$75.75$81,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2016Lilly Endowment IncMajor ShareholderSell190,000$75.86$14,413,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Donald A ZakrowskiCAOSell1,600$75.86$121,376.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2016Lilly Endowment IncMajor ShareholderSell180,000$75.44$13,579,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2016Alfonso G ZuluetaSVPSell12,000$76.27$915,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2016Lilly Endowment IncMajor ShareholderSell200,000$74.29$14,858,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2016Stephen F FrySVPSell15,230$78.87$1,201,190.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016David A. RicksSVPSell5,733$77.66$445,224.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016Derica W. RiceCFOSell10,483$77.78$815,367.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/1/2016Jackson P TaiDirectorBuy3,170$78.62$249,225.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2016Alfonso G ZuluetaSVPSell5,000$78.75$393,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/21/2015Lilly Endowment IncMajor ShareholderSell205,000$86.00$17,630,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2015Lilly Endowment IncMajor ShareholderSell215,000$85.60$18,404,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2015Enrique A ConternoVPSell25,000$83.88$2,097,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2015Lilly Endowment Incmajor shareholderSell210,000$85.09$17,868,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2015Lilly Endowment Incmajor shareholderSell205,000$84.54$17,330,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2015Lilly Endowment Incmajor shareholderSell200,000$82.28$16,456,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/9/2015Lilly Endowment Incmajor shareholderSell215,000$85.86$18,459,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2015Lilly Endowment Incmajor shareholderSell260,000$86.46$22,479,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2015Lilly Endowment Incmajor shareholderSell250,000$89.04$22,260,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Lilly Endowment IncMajor ShareholderSell210,000$82.39$17,301,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Lilly Endowment IncMajor ShareholderSell200,000$77.90$15,580,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2015Jeffrey N SimmonsSVPSell20,000$78.08$1,561,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2015Lilly Endowment IncMajor ShareholderSell190,000$73.43$13,951,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2015Lilly Endowment IncMajor ShareholderSell200,000$72.83$14,566,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2015Lilly Endowment IncMajor ShareholderSell195,000$73.28$14,289,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2015Lilly Endowment IncMajor ShareholderSell200,000$73.09$14,618,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/30/2015Lilly Endowment IncMajor ShareholderSell180,000$73.94$13,309,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Lilly Endowment IncMajor ShareholderSell190,000$76.97$14,624,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Stephen F FrySVPSell4,000$69.27$277,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015David A RicksSVPSell3,147$69.99$220,258.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015Derica W RiceCFOSell5,316$70.00$372,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015Jan M LundbergEVPSell11,085$70.08$776,836.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Jan M LundbergEVPSell121,711$70.78$8,614,704.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015David A RicksSVPSell4,769$71.51$341,031.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Derica W RiceCFOSell10,068$71.84$723,285.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014Lilly Endowment IncMajor ShareholderSell190,000$71.92$13,664,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2014Lilly Endowment IncMajor ShareholderSell180,000$70.14$12,625,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014Lilly Endowment IncMajor ShareholderSell200,000$67.73$13,546,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2014Lilly Endowment IncMajor ShareholderSell180,000$67.00$12,060,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2014Fionnuala M WalshSVPSell15,000$67.00$1,005,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Enrique A ConternoVPSell5,000$66.03$330,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Fionnuala M WalshSVPSell7,376$66.58$491,094.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Lilly Endowment IncMajor ShareholderSell190,000$66.40$12,616,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2014Lilly Endowment IncMajor ShareholderSell175,000$66.58$11,651,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2014Maria A CroweInsiderSell2,750$65.77$180,867.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/6/2014Lilly Endowment IncMajor ShareholderSell210,000$65.63$13,782,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Enrique A ConternoVPSell5,000$64.86$324,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/30/2014Lilly Endowment IncMajor ShareholderSell200,000$65.07$13,014,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Lilly Endowment IncMajor ShareholderSell210,000$64.77$13,601,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014Lilly Endowment IncMajor ShareholderSell200,000$63.99$12,798,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Enrique A ConternoVPSell5,000$63.60$318,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2014Lilly Endowment IncMajor ShareholderSell250,000$63.03$15,757,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/28/2014Susan MahonySVPSell2,065$63.30$130,714.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2014Enrique A ConternoVPSell10,000$63.79$637,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2014Susan MahonySVPSell30,000$63.90$1,917,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Lilly Endowment IncMajor ShareholderSell235,000$62.30$14,640,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/25/2014Lilly Endowment IncMajor ShareholderSell245,000$62.68$15,356,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2014Lilly Endowment IncMajor ShareholderSell230,000$61.55$14,156,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Lilly Endowment IncMajor ShareholderSell200,000$58.73$11,746,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014Lilly Endowment IncMajor ShareholderSell190,000$59.53$11,310,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2014Lilly Endowment Incmajor shareholderSell230,000$58.90$13,547,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2014Jackson TaiDirectorBuy17,157$59.19$1,015,522.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2014Lilly Endowment Incmajor shareholderSell210,000$59.33$12,459,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2014Lilly Endowment Incmajor shareholderSell190,000$58.79$11,170,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2014Lilly Endowment Incmajor shareholderSell200,000$59.43$11,886,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2014Lilly Endowment Incmajor shareholderSell150,000$58.64$8,796,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013Enrique ConternoVPSell5,000$53.79$268,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2013Jacques TapieroSVPSell7,500$53.74$403,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013Enrique A ConternoVPSell5,000$51.43$257,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2013Enrique A ConternoVPSell5,000$52.45$262,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2013Enrique A ConternoVPSell5,000$56.15$280,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013Jeffrey N SimmonsSVPSell10,000$54.49$544,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/26/2013Susan MahonySVPSell5,000$56.00$280,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Eli Lilly and (NYSE:LLY)
DateHeadline
07/26/16 05:13 PMEli Lilly, McDonald's Net Rise; 3M, Caterpillar, Verizon Net Plunge
07/26/16 05:13 PMWhy Eli Lilly Earnings Are So Dynamic
07/26/16 07:59 AMLilly sales beat estimates on demand for new drugs
07/26/16 07:59 AMLilly beats Street 2Q forecasts
07/26/16 07:59 AMEli Lilly (LLY) Tops on Q2 Earnings & Revenues
07/26/16 07:59 AMLilly 2Q Profit, Sales Jump on New Drugs
07/26/16 07:59 AMLilly Touts Decade of Pipeline Promise
07/26/16 07:59 AMEli Lilly and Company Files a Form 8-K
07/26/16 07:59 AMLilly beats analyst expectations, lays out bright outlook for rest of decade
07/26/16 07:59 AMBRIEF-Eli Lilly reports quarterly earnings of $0.71 per share
07/26/16 07:54 AMEli Lilly (LLY) Stock Rising After Mixed Q2 Results -
07/26/16 07:49 AMLilly sales beat estimates, helped by newer drugs -
07/26/16 07:35 AMTop Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016 -
07/26/16 07:33 AMEli Lilly CEO: Getting Back to Annual Dividend Increase -
07/26/16 06:37 AMEli Lilly Revenue Helped by Sales of New Drugs - Wall Street Journal - Wall Street JournalEli Lilly Revenue Helped by Sales of New DrugsWall Street JournalEli Lilly & Co. reported Tuesday that revenue rose more than expected in the most recent quarter, as sales of new drugs padded increases in established products. “Lilly is in the midst of one of the most productive periods of new product launches in ...Eli Lilly (LLY) Tops on Q2 Earnings amp; RevenuesZacks.comLilly sales beat estimates on demand for new drugsReutersEli Lilly & Co. (LLY) Reports In-Line Q2 EPS; Offers Longer-Term Guidance UpdateStreetInsider.comSan Francisco Chronicle -TheStreet.com -Finance Daily -Street Updatesall 27 news articles »
07/25/16 09:29 AMLGBT Bigotry And The Steep Fall Of Mike Pence
07/25/16 08:33 AMEli Lilly Has Catalysts Ahead -
07/24/16 04:33 PMEli Lilly : The Atlantic - Convention
07/22/16 04:54 PMCombining new and old drugs improves survival for soft-tissue cancer patients
07/22/16 04:54 PMStock Update: Eli Lilly
07/22/16 01:20 PMHow investor is playing Eli Lilly for rally -
07/22/16 12:07 PMWhat Are Lilly’s 2Q16 Estimates and Expectations for Elanco? -
07/22/16 12:07 PMUnderstanding Lilly’s New Product Expectations for 2Q16 -
07/22/16 12:07 PMInside Lilly’s 2Q16 Estimates for Its Cardiovascular Franchise -
07/22/16 12:07 PMInside Lilly’s 2Q16 Estimates for Its Oncology Franchise -
07/22/16 12:07 PMInside Lilly’s 2Q16 Estimates for Its Neuroscience Franchise -
07/22/16 07:55 AMCharter Trust Co Lowers stake in Eli Lilly and Co (LLY) - Trade Calls
07/21/16 05:09 PMEli Lilly & Co. (LLY) Will Present Data from 25+ Studies at AAIC 2016 - StreetInsider.com
07/21/16 11:07 AMEli Lilly : Grassi Investment Management buys $8,866,972 stake in Eli Lilly and Co (LLY)
07/21/16 11:07 AMEli Lilly & Co. (LLY) Will Present Data from 25+ Studies at AAIC 2016
07/21/16 09:08 AMThe Best Way to Lead During a Crisis -
07/21/16 07:45 AMWhy Eli Lilly (LLY) Might Surprise This Earnings Season -
07/21/16 07:00 AMDiversity of Lilly's Alzheimer's Disease Pipeline Showcased at the Alzheimer's Association International Conference® 2016 (AAIC® 2016) - [PR Newswire] - INDIANAPOLIS, July 21, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced it will present findings from more than 25 research studies at the upcoming Alzheimer's Association International ...
07/20/16 03:06 PMCadinha & Co LLC Decreased Stake in Eli Lilly & Co (NYSE:LLY) by $7.96 Million as Shares Declined - Consumer Eagle
07/20/16 03:06 PMRecent Analysts Moves of Stocks: Eli Lilly and Company (NYSE:LLY) , Akorn, Inc. (NASDAQ:AKRX) - Street Updates
07/20/16 03:06 PMEli Lilly: Executive Compensation And Other Metrics - Seeking Alpha
07/20/16 03:06 PMEli Lilly and Co (NYSE:LLY) & Prologis Inc (NYSE:PLD) Traders Recap - Money News (press release)
07/20/16 03:06 PMEli Lilly & Co. (LLY) Announces FDA Approval of Expanded Synjardy Indication - StreetInsider.com
07/20/16 10:54 AMHow this biotech analyst thinks the presidential election will impact the overall health care space -
07/20/16 07:55 AMEli Lilly: Executive Compensation And Other Metrics
07/19/16 05:03 PMEli Lilly’s Valuation Cheat Sheet for 2Q16
07/19/16 04:08 PMEli Lilly & Co. : LLY-US: Dividend Analysis : August 15th, 2016 (record date) : By the numbers : July 19, 2016 -
07/19/16 03:35 PMWhat Lilly Expects for Revenue Growth in 2Q16 -
07/19/16 03:35 PMWhat’s Expected of Eli Lilly’s 2Q16 Earnings? -
07/19/16 11:04 AMFDA expands indication for Synjardy to treatment-naive adults with type 2 diabetes
07/19/16 11:04 AMU.S. FDA expands indication for type 2 diabetes treatment Synjardy® (empagliflozin/metformin hydrochloride) to include treatment-naïve adults
07/19/16 11:04 AMEli Lilly & Co. (LLY) Announces FDA Approval of Expanded Synjardy Indication
07/19/16 08:58 AMEli Lilly Gets FDA Expanded Indication For Type 2 Diabetes Treatment Synjardy To Add Treatment-Naïve Adults - Eli Lilly and Company (NYSE: LLY) disclosed that the FDA has approved an expanded indication for Synjardy® (empagliflozin and metformin hydrochloride) tablets to include treatment-naïve adults with type 2 diabetes (T2D). According to the company, SYNJARDY, from Boehringer Ingelheim and Eli Lilly, was indicated as an adjunct to diet, as well as exercise to enhance glycemic control in adults with T2D when treatment with both empagliflozin and metformin is ...Full story available on Benzinga.com
07/18/16 10:17 AMDelhi Gang Rape, Telangana Judges, PACL, Virbhadra Singh & more
07/17/16 09:17 AMEli Lilly Summer Challenge at William Tennent teaching students real-life job skills

Social

About Eli Lilly and

Eli Lilly and logoEli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment operates through the Company's Elanco division, which develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, such as Humalog and Humalog Mix 75/25; neuroscience products, such as Cymbalta and Zyprexa; oncology products, such as Alimta and Cyramza, and cardiovascular products, such as Cialis and ReoPro. The Company's animal health products segment includes products for food animals, such as Rumensin and Posilac; products for companion animals, such as Onsior and Osurnia, and Novartis Animal Health (Novartis AH) products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: LLY
  • CUSIP: 53245710
Key Metrics:
  • Previous Close: $82.09
  • 50 Day Moving Average: $77.08
  • 200 Day Moving Average: $75.79
  • P/E Ratio: 37.83
  • P/E Growth: 1.90
  • Market Cap: $87.01B
  • Beta: 0.18
  • Current Year EPS Consensus Estimate: $3.56 EPS
  • Next Year EPS Consensus Estimate: $3.99 EPS
Additional Links:
Eli Lilly and (NYSE:LLY) Chart for Wednesday, July, 27, 2016